BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9267781)

  • 1. Staging prostate cancer--1997: current methods and limitations.
    Bostwick DG
    Eur Urol; 1997; 32 Suppl 3():2-14. PubMed ID: 9267781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of prostate cancer.
    Bostwick DG; Myers RP; Oesterling JE
    Semin Surg Oncol; 1994; 10(1):60-72. PubMed ID: 7509505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI; Walsh PC; Carmichael M; Brendler CB
    JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors.
    Tiguert R; Gheiler EL; Grignon DJ; Littrup PJ; Sakr W; Pontes JE; Wood DP
    J Urol; 2000 May; 163(5):1486-90. PubMed ID: 10751863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.
    Smith JA; Scardino PT; Resnick MI; Hernandez AD; Rose SC; Egger MJ
    J Urol; 1997 Mar; 157(3):902-6. PubMed ID: 9072596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations.
    Ohori M; Wheeler TM; Scardino PT
    Cancer; 1994 Jul; 74(1):104-14. PubMed ID: 7516262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.
    Augustin H; Graefen M; Palisaar J; Blonski J; Erbersdobler A; Daghofer F; Huland H; Hammerer PG
    J Clin Oncol; 2003 Aug; 21(15):2860-8. PubMed ID: 12885802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration.
    Stormont TJ; Farrow GM; Myers RP; Blute ML; Zincke H; Wilson TM; Oesterling JE
    Urology; 1993 Jan; 41(1):3-8. PubMed ID: 7678359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Tsui KH; Chang PL; Wang TM; Hsieh ML
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate.
    Terris MK; McNeal JE; Stamey TA
    J Urol; 1992 Mar; 147(3 Pt 2):864-9. PubMed ID: 1371562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative staging of prostatic carcinoma: evaluation of the role of transrectal echography].
    Lorusso A; Curatolo C; Cirillo Marucco E; Ludovico GM; Limitone DA; Pagliarulo A
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):83-5. PubMed ID: 9162382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inaccuracies in assignment of clinical stage for localized prostate cancer.
    Reese AC; Sadetsky N; Carroll PR; Cooperberg MR
    Cancer; 2011 Jan; 117(2):283-9. PubMed ID: 21210472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUS for locoregional staging of prostate cancer--a pilot study.
    Artifon EL; Sakai P; Ishioka S; Silva AF; Maluf F; Chaves D; Matuguma S; Pompeo A; Lucon AM; Srougi M; Bhutani MS
    Gastrointest Endosc; 2007 Mar; 65(3):440-7. PubMed ID: 17321246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of transrectal MRI in the staging of localized prostate cancer].
    Pariente JL; Jacob F; Trillaud H; Deminiere C; Khan H; Ferrière JM; Grenier N; Le Guillou M
    Prog Urol; 1997 Jun; 7(3):449-54. PubMed ID: 9273074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in prostate cancer].
    Bonkhoff H
    Pathologe; 2005 Nov; 26(6):433-43. PubMed ID: 16205900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.